MSH|^~\&|Corepoint|TDL|UCLH|UCLH|201307290941||ORU^R01|0729094213U446388|P|2.3PID||7048303247^^NHS|40803204^^HOSP||ALNOBANI^ALINA||19770905|F|||^^^^N22 8JSPV1|||SOPD^Surgical OPD, ASH^^^^^^^OP||||||MA1^ADAMO, MR. MORC|RE|13U446388|13U446388||CM||||201307290941OBR|1|13U446388|13U446388|BON^BONE PROFILE^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251358||CC|FOBX|1|NM|ALP^Alkaline phosphatase^Winpath||104|IU/L|35-104||||FOBX|2|NM|ALB^Albumin^Winpath||48|g/L|34-50||||FOBX|3|NM|CA^Calcium^Winpath||2.43|mmol/L|2.15-2.55||||FOBX|4|NM|PHOS^Phosphate^Winpath||1.07|mmol/L|0.87-1.45||||FOBR|2|13U446388|13U446388|IRON^IRON PROFILE^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251359||CC|FOBX|1|NM|FE^Iron^Winpath||21.6|umol/L|6.6-26.0||||FOBX|2|NM|UIBC^Unsaturated iron binding^Winpath||30.9|umol/L|20-66||||FOBX|3|NM|TIBC^Total iron binding capacity^Winpath||53|umol/L|41-77||||FOBX|4|NM|IBS^Iron-binding saturation^Winpath||41|%|15-50||||FOBR|3|13U446388|13U446388|HBA^HAEMOGLOBIN A1C^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251229||CC|FOBX|1|NM|HBA^Haemoglobin A1c (%)^Winpath||5.5|% total Hb|4.0-6.0||||FNTE|1||HbA1c results traceable to the IFCC referenceNTE|1||method effective 26th April 2010NTE|1||Please note analyser changed from Tosoh G7 to G8NTE|1||on 06/05/2010OBX|2|NM|GHBI^Haemoglobin A1c (mmol/mol)^Winpath||37|mmol/mol|20-42||||FOBR|4|13U446388|13U446388|GLU^GLUCOSE^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307261221||CC|FOBX|1|FT|GLU^Glucose^Winpath||Cancelled - Regret sample lost in laboratory\.br\ accident.|mmol/L|||||FOBR|5|13U446388|13U446388|LPF^LIPID PROFILE^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251359||CC|FOBX|1|NM|CHOL^Cholesterol^Winpath||5.0|mmol/L|2.5-5.0||||FOBX|2|NM|TRIG^Triglyceride^Winpath||1.7|mmol/L|0.4-2.3||||FOBX|3|NM|HDL^HDL Cholesterol^Winpath||0.7|mmol/L|1.2-1.7|L|||FOBX|4|NM|LDLU^LDL Cholesterol^Winpath||3.5|mmol/L|0-3.5||||FOBX|5|NM|CHDR^Cholesterol:HDL ratio^Winpath||7.1||||||FOBR|6|13U446388|13U446388|BFOL^VITAMIN B12 \T\ SERUM FOLAT^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251914||CC|FOBX|1|NM|VB12^Vitamin B12^Winpath||702|pg/mL|191-663|H|||FOBX|2|NM|SFOL^Serum folate^Winpath||17.6|ng/mL|4.6-18.7||||FNTE|1||Folate result assumes no folic acid supplementNTE|1||on day of samplingOBR|7|13U446388|13U446388|FBCY^FULL BLOOD COUNT^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307241926||H1|FOBX|1|NM|WCC^White cell count^Winpath||7.28|x10\S\9/L|3.0-10.0||||FOBX|2|NM|RCC^Red cell count^Winpath||4.55|x10\S\12/L|3.95-5.15||||FOBX|3|NM|HGB^Haemoglobin^Winpath||14.1|g/dl|11.5-15.5||||FOBX|4|NM|HCTU^HCT^Winpath||0.424|L/L|0.33-0.45||||FOBX|5|NM|MCVU^MCV^Winpath||93.2|fL|80-99||||FOBX|6|NM|MCHU^MCH^Winpath||31.0|pg|27.0-33.5||||FOBX|7|NM|CHCU^MCHC^Winpath||33.3|g/dl|32.0-36.0||||FOBX|8|NM|RDWU^RDW^Winpath||14.8|%|11.5-15.0||||FOBX|9|NM|PLT^Platelet count^Winpath||364|x10\S\9/L|150-400||||FOBX|10|NM|MPVU^MPV^Winpath||12.2|fL|7-13||||FOBR|8|13U446388|13U446388|FBCZ^DIFFERENTIAL^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307241926||H1|FOBX|1|NM|NE^Neutrophils^Winpath||41.5%  3.02|x10\S\9/L|2.0-7.5||||FOBX|2|NM|LY^Lymphocytes^Winpath||44.9%  3.27|x10\S\9/L|1.2-3.65||||FOBX|3|NM|MO^Monocytes^Winpath||7.8%  0.57|x10\S\9/L|0.2-1.0||||FOBX|4|NM|EO^Eosinophils^Winpath||5.4%  0.39|x10\S\9/L|0.0-0.4||||FOBX|5|NM|BA^Basophils^Winpath||0.4%  0.03|x10\S\9/L|0.0-0.1||||FOBR|9|13U446388|13U446388|VITD^25-HYDROXY VITAMIN D^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307290941||CS|FOBX|1|NM|25D2^25-hydroxy Vitamin D2^Winpath||<7|nmol/L|||||FOBR|10|13U446388|13U446388|PTH^PARATHYROID HORMONE^WinPath||201307241746|201307241641|||||||||MA1^ADAMO, MR. M||||||201307251826||CS|FOBX|1|NM|PTH^Parathyroid hormone^Winpath||6.9|pmol/L|1.6-6.9||||F